Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285)

Henan Lingrui Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 6, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	11,995	9,649	7,358	8,920	4,809	5,621
Market Cap Growth	38.17%	31.14%	-17.51%	85.47%	-14.44%	27.46%
Enterprise Value	11,068	8,482	6,324	8,108	4,064	5,063
Last Close Price	21.30	16.56	12.16	14.15	7.29	8.24
PE Ratio	17.71	16.98	15.81	24.67	14.78	19.09
Forward PE	17.33	17.39	14.45	15.43	15.43	18.25
PS Ratio	3.35	2.91	2.45	3.31	2.06	2.61
PB Ratio	4.17	3.45	2.88	3.90	2.07	2.53
P/TBV Ratio	5.18	3.73	3.13	4.37	2.31	2.86
P/FCF Ratio	19.63	12.18	9.11	11.60	12.70	14.37
P/OCF Ratio	21.31	11.86	8.81	10.55	10.67	12.49
EV/Sales Ratio	3.11	2.56	2.11	3.01	1.74	2.35
EV/EBITDA Ratio	14.05	12.76	13.65	18.11	10.57	12.78
EV/EBIT Ratio	15.61	14.40	16.25	21.54	12.85	15.40
EV/FCF Ratio	18.12	10.71	7.83	10.55	10.73	12.95
Debt / Equity Ratio	0.01	0.07	0.06	0.12	0.07	0.13
Debt / EBITDA Ratio	0.03	0.31	0.34	0.63	0.43	0.71
Debt / FCF Ratio	0.03	0.26	0.20	0.37	0.44	0.72
Asset Turnover	0.75	0.73	0.74	0.74	0.69	0.67
Inventory Turnover	2.14	1.86	1.83	1.86	1.77	1.62
Quick Ratio	0.94	1.11	1.16	1.16	1.45	1.41
Current Ratio	1.18	1.37	1.47	1.48	1.80	1.73
Return on Equity (ROE)	24.05%	21.21%	19.21%	15.73%	14.28%	13.59%
Return on Assets (ROA)	9.31%	8.07%	5.98%	6.49%	5.84%	6.39%
Return on Capital (ROIC)	15.41%	12.86%	9.20%	9.31%	7.92%	8.43%
Earnings Yield	5.65%	5.89%	6.32%	4.05%	6.77%	5.24%
FCF Yield	5.09%	8.21%	10.98%	8.62%	7.87%	6.96%
Dividend Yield	3.81%	4.83%	4.94%	3.53%	5.49%	3.64%
Payout Ratio	67.58%	60.60%	62.08%	61.91%	55.03%	33.39%
Buyback Yield / Dilution	0.51%	0.30%	-0.26%	0.24%	1.22%	2.60%
Total Shareholder Return	4.33%	5.13%	4.68%	3.77%	6.71%	6.25%

Source: S&P Capital IQ. Standard template. Financial Sources.